Abstract
Breast carcinoma is the most common malignancy among women in developed countries. Because family history remains the strongest single predictor of breast cancer risk, attention has focused on the role of highly penetrant, dominantly inherited genes in cancer-prone kindreds1. BRCA1 was localized to chromosome 17 through analysis of a set of high-risk kindreds2, and then identified four years later by a positional cloning strategy3. BRCA2 was mapped to chromosomal 13q at about the same time4. Just fifteen months later, Wooster et al.5 reported a partial BRCA2 sequence and six mutations predicted to cause truncation of the BRCA2 protein. While these findings provide strong evidence that the identified gene corresponds to BRCA2, only two thirds of the coding sequence and 8 out of 27 exons were isolated and screened; consequently, several questions remained unanswered regarding the nature of BRCA2 and the frequency of mutations in 13q-linked families. We have now determined the complete coding sequence and exonic structure of BRCA2 (GenBank accession ♯U43746), and examined its pattern of expression. Here, we provide sequences for a set of PCR primers sufficient to screen the entire coding sequence of BRCA2 using genomic DMA. We also report a mutational analysis of BRCA2 in families selected on the basis of linkage analysis and/or the presence of one or more cases of male breast cancer. Together with the specific mutations described previously, our data provide preliminary insight into the BRCA2 mutation profile.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kelsey, J.L. & Gammon, M.D. The epidemiology of breast cancer. CA Cancer J. Clinic. 41, 147–165 (1991).
Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250, 1684–1689 (1990).
Miki, Y. et al. A strong candidated for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science. 266, 66–71 (1994).
Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 265, 2088–2090 (1994).
Wooster, R. et al. Identification of the breast cancer gene BRCA2. Nature. 378, 789–791 (1995).
Schutte, M. et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA. 92, 5950–5954 (1995).
Stone, S. et al.Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55, 2988–2994 (1995).
Simard, J. et al. Generation of a transcription map of the BRCA2 region. Am. J. Hum. Genet. 57, (suppl) 1566 (1995).
Friedman, L.S. et al. Novel inherited mutations and variable expressivity of BRCA1 alleles including the founder mutation 185 del AG in Ashkenazi Jewish families. Am. J. Hum. Genet. 57, 1284–1297 (1995).
Szabo, C.I. & King, M.-C. Inherited breast and ovarian cancer. Hum. Mol.Genef. 4, 1811–1817 (1995).
Shattuck-Eidens, D. et al. A comparative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implication for presymptomatic testing and screening. JAMA. 273, 535–541 (1995).
Parimoo, S. et al. cDNA selection: Efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. Proc. Natl. Acad. Sci. USA. 88, 9623–9627 (1991).
Rommens, J.M. et al. Towards a transcriptional map of the q21 -q22 region of chromosome 7. In ‘Identification of transcribed sequences’, (eds Hochgeschwender, U. & Gardiner, K.) pp. 65–79 (Plenum Press, New York, 1994).
Lovett, M., Kere, J. Direct selection: A method for the isolation of cDNAs encoded by large genomic regions. Proc. Natl. Acad. Sci. USA. 88, 9628–9632 (1991).
Nattier, T. et al. Analysis of hybrid selection in the search for BRCA1. Mamm. Genome 6, 873–879 (1995).
Church, D.M. et al. Identification of human chromosome 9 specific genes using exon amplification. Hum. Mol. Genet. 2, 1915 (1993).
Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 22–29 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tavtigian, S., Simard, J., Rommens, J. et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12, 333–337 (1996). https://doi.org/10.1038/ng0396-333
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0396-333
This article is cited by
-
Germline BRCA2 pathogenic variants in pediatric ganglioglioma: Case report and review of the literature
Child's Nervous System (2024)
-
The association between age at breast cancer diagnosis and prevalence of pathogenic variants
Breast Cancer Research and Treatment (2023)
-
Association between single-nucleotide polymorphisms in miRNA and breast cancer risk: an updated review
Biological Research (2021)
-
Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)
BMC Cancer (2020)
-
Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples
BMC Cancer (2019)
